Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Janssen

Showing results (291-300 of 318) with videos related to

Pageof 32
Sort By:
Environmental Science & Technology|March 28, 2025
Sulfate Reduction Drives Elevated Methylmercury Formation in the Water Column of a Eutrophic Freshwater LakeBenjamin D Peterson, Sarah E Janssen, Brett A Poulin, et al.
American Journal of Physiology. Endocrinology and Metabolism|November 16, 2006
Calpain-10 variants and haplotypes are associated with polycystic ovary syndrome in CaucasiansCaren Vollmert, Susanne Hahn, Claudia Lamina, et al.
BMJ Quality & Safety|January 9, 2025
Duration of antibiotic therapy in the intensive care unit: factors influencing decision-making during multidisciplinary meetingsRobin M E Janssen, Anke J M Oerlemans, Nynke Bos, et al.
Journal of Science and Medicine in Sport|April 24, 2026
Association of cardiovascular health status and cardiac troponin proteoforms following endurance exercise: a case series of long-distance walkersTom T J Luiken, Sacha K Lamers, Sylvan L J E Janssen, et al.
Journal of Critical Care|May 26, 2026
Variation in antibiotic use across intensive care units in the NetherlandsRobin M E Janssen, Izak A R Yasrebi-de Kom, Joanna E Klopotowska, et al.
Journal for Immunotherapy of Cancer|March 22, 2019
A phase II clinical trial of adoptive transfer of haploidentical natural killer cells for consolidation therapy of pediatric acute myeloid leukemiaRosa Nguyen, Huiyun Wu, Stanley Pounds, et al.
The Science of the Total Environment|March 21, 2021
Examining historical mercury sources in the Saint Louis River estuary: How legacy contamination influences biological mercury levels in Great Lakes coastal regionsSarah E Janssen, Joel C Hoffman, Ryan F Lepak, et al.
Journal for Immunotherapy of Cancer|March 30, 2020
Longitudinal NK cell kinetics and cytotoxicity in children with neuroblastoma enrolled in a clinical phase II trialRosa Nguyen, Natasha Sahr, April Sykes, et al.
Brain Communications|August 8, 2024
The STELLAR trial: a phase II/III randomized trial of high-dose, intermittent sunitinib in patients with recurrent glioblastomaJorien B E Janssen, Cyrillo G Brahm, Chantal M L Driessen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 24, 2017
A Pilot Trial of Humanized Anti-GD2 Monoclonal Antibody (hu14.18K322A) with Chemotherapy and Natural Killer Cells in Children with Recurrent/Refractory NeuroblastomaSara M Federico, M Beth McCarville, Barry L Shulkin, et al.
Pageof 32

Showing results (291-300 of 318) with videos related to

Sort By:
Pageof 32
Environmental Science & Technology|March 28, 2025
Sulfate Reduction Drives Elevated Methylmercury Formation in the Water Column of a Eutrophic Freshwater LakeBenjamin D Peterson, Sarah E Janssen, Brett A Poulin, et al.
American Journal of Physiology. Endocrinology and Metabolism|November 16, 2006
Calpain-10 variants and haplotypes are associated with polycystic ovary syndrome in CaucasiansCaren Vollmert, Susanne Hahn, Claudia Lamina, et al.
BMJ Quality & Safety|January 9, 2025
Duration of antibiotic therapy in the intensive care unit: factors influencing decision-making during multidisciplinary meetingsRobin M E Janssen, Anke J M Oerlemans, Nynke Bos, et al.
Journal of Science and Medicine in Sport|April 24, 2026
Association of cardiovascular health status and cardiac troponin proteoforms following endurance exercise: a case series of long-distance walkersTom T J Luiken, Sacha K Lamers, Sylvan L J E Janssen, et al.
Journal of Critical Care|May 26, 2026
Variation in antibiotic use across intensive care units in the NetherlandsRobin M E Janssen, Izak A R Yasrebi-de Kom, Joanna E Klopotowska, et al.
Journal for Immunotherapy of Cancer|March 22, 2019
A phase II clinical trial of adoptive transfer of haploidentical natural killer cells for consolidation therapy of pediatric acute myeloid leukemiaRosa Nguyen, Huiyun Wu, Stanley Pounds, et al.
The Science of the Total Environment|March 21, 2021
Examining historical mercury sources in the Saint Louis River estuary: How legacy contamination influences biological mercury levels in Great Lakes coastal regionsSarah E Janssen, Joel C Hoffman, Ryan F Lepak, et al.
Journal for Immunotherapy of Cancer|March 30, 2020
Longitudinal NK cell kinetics and cytotoxicity in children with neuroblastoma enrolled in a clinical phase II trialRosa Nguyen, Natasha Sahr, April Sykes, et al.
Brain Communications|August 8, 2024
The STELLAR trial: a phase II/III randomized trial of high-dose, intermittent sunitinib in patients with recurrent glioblastomaJorien B E Janssen, Cyrillo G Brahm, Chantal M L Driessen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 24, 2017
A Pilot Trial of Humanized Anti-GD2 Monoclonal Antibody (hu14.18K322A) with Chemotherapy and Natural Killer Cells in Children with Recurrent/Refractory NeuroblastomaSara M Federico, M Beth McCarville, Barry L Shulkin, et al.
Pageof 32